Moreover, PML expression is required to maintain self-renewal and avoid cell death by anoikis in CML and TNBC, respectively, suggesting that some tumors may even rely on PML expression to sustain the malignant phenotype. Here, PML is linked to chronic myelogenous leukemia, BCR-ABL1 positive.